Impact of Previous Alopecia Areata Treatment on Efficacy Responses up to Week 48 Following Ritlecitinib Treatment: A Post Hoc Analysis

• Main Authors: Jennifer Fu (Author), Alexander Egeberg (Author), Susan Holmes (Author), Sergio Vano-Galvan (Author), Martin Steinhoff (Author), Roger Edwards (Author), Gianluca Bonfanti (Author), Ranjit Nagra (Author), Robert Wolk (Author), Helen Tran (Author), Ernest Law (Author)
• Format: Book
• Published: Adis, Springer Healthcare, 2024-09-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Introduction Patients with alopecia areata (AA) may have received several therapies for management of AA during their lives. In the ALLEGRO phase 2b/3 (NCT03732807) study, the oral JAK3/TEC family kinase inhibitor ritlecitinib demonstrated efficacy and an acceptable safety profile in patien...